- Home
- RILY vs SEER Comparison
RILY vs SEER Comparison
Compare RILY & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILY
- SEER
- Stock Information
- Founded
- RILY 1973
- SEER 2017
- Country
- RILY United States
- SEER United States
- Employees
- RILY N/A
- SEER N/A
- Industry
- RILY Investment Managers
- SEER Medicinal Chemicals and Botanical Products
- Sector
- RILY Finance
- SEER Health Care
- Exchange
- RILY Nasdaq
- SEER Nasdaq
- Market Cap
- RILY 142.1M
- SEER 132.4M
- IPO Year
- RILY 2007
- SEER 2020
- Fundamental
- Price
- RILY $4.37
- SEER $1.93
- Analyst Decision
- RILY
- SEER Hold
- Analyst Count
- RILY 0
- SEER 1
- Target Price
- RILY N/A
- SEER $3.00
- AVG Volume (30 Days)
- RILY 4.5M
- SEER 302.5K
- Earning Date
- RILY 03-17-2025
- SEER 05-07-2025
- Dividend Yield
- RILY 11.55%
- SEER N/A
- EPS Growth
- RILY N/A
- SEER N/A
- EPS
- RILY N/A
- SEER N/A
- Revenue
- RILY $854,383,000.00
- SEER $14,170,000.00
- Revenue This Year
- RILY N/A
- SEER $29.77
- Revenue Next Year
- RILY N/A
- SEER $47.98
- P/E Ratio
- RILY N/A
- SEER N/A
- Revenue Growth
- RILY N/A
- SEER N/A
- 52 Week Low
- RILY $2.73
- SEER $1.56
- 52 Week High
- RILY $40.09
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- RILY 45.82
- SEER 26.24
- Support Level
- RILY $4.70
- SEER $1.91
- Resistance Level
- RILY $5.82
- SEER $2.37
- Average True Range (ATR)
- RILY 1.07
- SEER 0.12
- MACD
- RILY -0.04
- SEER -0.03
- Stochastic Oscillator
- RILY 36.61
- SEER 10.89
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.